- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04496427
Observational Study to Determine the Efficacy and Safety of Potenfill for Temporary Penile Enhancement
July 29, 2020 updated by: Medy-Tox
A Single-center, Long-term, Observational Study to Determine the Efficacy and Safety of Potenfill for Temporary Penile Enhancement
This is an observational study to determine the efficacy and safety of Potenfill for temporary penile enhancement.
The pivotal study of Potenfill has already been completed and this observational study determines the long-term efficacy and safety for up to 24 months in subjects who have been participated and treated in the pivotal study.
Study Overview
Status
Completed
Conditions
Study Type
Observational
Enrollment (Actual)
13
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Gangdong-gu
-
Seoul, Gangdong-gu, Korea, Republic of, 05355
- Kangdong Sacred Heart Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
19 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Male
Sampling Method
Non-Probability Sample
Study Population
Males over 19 and under 65 who have participated in the previous clinical investigation (pivotal) and were treated with the investigational medical device and completed all the anticipated visits.
Description
Inclusion Criteria:
- Males over 19 and under 65 who have participated in the previous clinical investigation (pivotal) and were treated with the investigational medical device and completed all the anticipated visits.
Exclusion Criteria:
- Subjects who have received any procedures or surgeries (penile enhancement procedure, HA filler, collagen, etc.) in the penile area from the time after the participation of the previous clinical investigation (pivotal) and before the screening for this clinical investigation.
- Subjects deemed as ineligible to participate by the investigator
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Other
- Time Perspectives: Prospective
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Satisfaction with the appearance of penis assessed by the Subject Satisfaction at 18 months after treatment with Potenfill compared to baseline
Time Frame: 18 months
|
Satisfaction with the physical appearance of the penis as assessed by the subject at 18 months after application of the investigational medical device compared to baseline.
The Subject Satisfaction score ranges from 1 (extremely unsatisfied) to 7 (extremely satisfied).
|
18 months
|
Satisfaction with the appearance of penis assessed by the Subject Satisfaction at 24 months after treatment with Potenfill compared to baseline
Time Frame: 24 months
|
Satisfaction with the physical appearance of the penis as assessed by the subject at 24 months after application of the investigational medical device compared to baseline.
The Subject Satisfaction score ranges from 1 (extremely unsatisfied) to 7 (extremely satisfied).
|
24 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 10, 2019
Primary Completion (Actual)
November 15, 2019
Study Completion (Actual)
December 11, 2019
Study Registration Dates
First Submitted
July 27, 2020
First Submitted That Met QC Criteria
July 29, 2020
First Posted (Actual)
August 3, 2020
Study Record Updates
Last Update Posted (Actual)
August 3, 2020
Last Update Submitted That Met QC Criteria
July 29, 2020
Last Verified
July 1, 2020
More Information
Terms related to this study
Other Study ID Numbers
- MT05-KR19PGE1101
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Penile Enhancement
-
Medy-ToxCompletedPenile Enhancement | Penile Girth EnhancementKorea, Republic of
-
HugelAssociacio catalana per a la recerca oncologica i les seves implicacions...Completed
-
Medy-ToxCompletedPenile EnhancementKorea, Republic of
-
CHA MEDITECH Co., Ltd.CompletedPenile Enhancement | Small PenisKorea, Republic of
-
Ludwig-Maximilians - University of MunichNational Institute of Nutrition and Seafood Research, NorwayCompleted
-
AllerganCompleted
-
Nootrobox, Inc.CompletedBiomedical EnhancementNetherlands
-
Allergan MedicalCompletedLip EnhancementUnited Kingdom
-
Jeanne Townsend, PhDNational Institute on Aging (NIA)Unknown
-
Allergan MedicalCompletedLip Volume EnhancementUnited Kingdom, France